KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Change in Inventory (2017 - 2025)

Johnson & Johnson (JNJ) has disclosed Change in Inventory for 17 consecutive years, with $46.0 million as the latest value for Q4 2025.

  • Quarterly Change in Inventory fell 48.89% to $46.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.5 billion through Dec 2025, up 28.55% year-over-year, with the annual reading at $1.5 billion for FY2025, 28.55% up from the prior year.
  • Change in Inventory hit $46.0 million in Q4 2025 for Johnson & Johnson, down from $748.0 million in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $1.3 billion in Q1 2023 to a low of -$519.0 million in Q1 2021.
  • Historically, Change in Inventory has averaged $361.6 million across 5 years, with a median of $354.0 million in 2021.
  • Biggest YoY gain for Change in Inventory was 337.11% in 2021; the steepest drop was 253.06% in 2021.
  • Year by year, Change in Inventory stood at $360.0 million in 2021, then soared by 66.67% to $600.0 million in 2022, then plummeted by 120.67% to -$124.0 million in 2023, then soared by 172.58% to $90.0 million in 2024, then tumbled by 48.89% to $46.0 million in 2025.
  • Business Quant data shows Change in Inventory for JNJ at $46.0 million in Q4 2025, $748.0 million in Q3 2025, and $510.0 million in Q2 2025.